Chronic agomelatine treatment alleviates icvAβ-induced anxiety and depressive-like behavior through affecting Aβ metabolism in the hippocampus in a rat model of Alzheimer's disease

Publication date: Available online 6 July 2021Source: Physiology & BehaviorAuthor(s): Kalina Ilieva, Milena Atanasova, Dimitrinka Atanasova, Lidia Kortenska, Jana Tchekalarova
Source: Physiology and Behavior - Category: Physiology Source Type: research